Views & Analysis Growing up different and not knowing why: My experience of r... Protracted diagnostic odysseys don’t only block access to rare disease treatments, they also leave people facing emotional turmoil all alone.
Views & Analysis Cytisinicline - the solution to stop smoking? Whether present in electronic or combustible cigarettes, nicotine is a highly addictive substance.
Views & Analysis The power of communication: engaging diverse groups in healt... Humans are diverse and communications to engage us need to be inclusive.
Patients The hidden danger of isolated congenital asplenia TEAM 4 Travis is an advocacy group with one objective – to ensure it doesn’t take an autopsy to diagnose isolated congenital asplenia.
Patients Patient involvement in trial design: looking to the future COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement.
Views & Analysis How accidental advocacy is amplifying the GM1 voice Rare disease families need to stand up and be counted if they want things to change said mum and advocate Christine Waggoner.
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.